USD 1.1 billion
Autoimmune Disease Diagnostics Market Size, Share, Growth Analysis, By Product(Reagents and consumables, Instruments), By Test Type(Antinuclear antibody tests, Urinalysis, C-reactive protein (CRP), Complete blood count (CBC)), By Disease Type(Systemic autoimmune disease (Rheumatoid arthritis, Systemic lupus erythematosus (SLE), Psoriasis, Multiple sclerosis), By End User(Hospitals, Diagnostics centers, Other end-users), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35D2178 |
Region:
Global |
Published Date: October, 2024
Pages:
157
|Tables:
59
|Figures:
75
Autoimmune Disease Diagnostics Market Insights
Global Autoimmune Disease Diagnostics Market size was valued at USD 4.38 billion in 2022 and is poised to grow from USD 4.56 billion in 2023 to USD 6.32 billion by 2031, growing at a CAGR of 4.15% during the forecast period (2024-2031).
The autoimmune disease diagnostics market plays a crucial role in the early detection, accurate diagnosis, and monitoring of autoimmune diseases. These diseases can affect multiple organs and systems, including the joints, skin, kidneys, heart, lungs, and nervous system, among others. Therefore, timely and accurate diagnosis is essential for effective disease management and treatment. The market has been witnessing significant growth due to several factors. Firstly, there has been an increase in the prevalence of autoimmune diseases worldwide. Factors such as genetic predisposition, environmental triggers, and lifestyle changes contribute to the rising incidence of these diseases. As a result, the demand for diagnostic tests to identify and monitor autoimmune diseases has increased substantially. Secondly, advancements in medical technology and diagnostic techniques have greatly improved the accuracy and efficiency of autoimmune disease diagnostics. Various laboratory tests, imaging techniques, and specialized assays are now available to aid in the identification of specific autoimmune disorders. These innovative diagnostic tools enable healthcare professionals to make more informed decisions regarding patient treatment plans. Furthermore, growing awareness among patients and healthcare providers about autoimmune diseases has fueled the demand for early detection and diagnosis. Recognizing the symptoms and initiating appropriate diagnostic procedures at an early stage can significantly improve patient outcomes and prevent further complications. In conclusion, the global market is experiencing substantial growth due to the increasing prevalence of autoimmune diseases, advancements in diagnostic technology, and rising awareness among patients and healthcare providers. The market holds immense potential for further innovation and development of diagnostic tools to aid in early detection and effective management of autoimmune diseases.
US Autoimmune Disease Diagnostics Market is poised to grow at a sustainable CAGR for the next forecast year.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Systemicc
Fastest Growth
Systemic
Growth Rate
6.6% CAGR
Global Autoimmune Disease Diagnostics Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Autoimmune Disease Diagnostics Market Segmental Analysis
Global Autoimmune Disease Diagnostics Market is segmented by Product, Test Type, Disease Type, End User, and Region. Based on Product, the market is segmented into Reagents and consumables, Instruments. Based on Test Type, the market is segmented into Antinuclear antibody tests, Urinalysis, C-reactive protein (CRP), Complete blood count (CBC), Autoantibody tests, Other tests. Based on Disease Type, the market is segmented into Systemic autoimmune disease (Rheumatoid arthritis, Systemic lupus erythematosus (SLE), Psoriasis, Multiple sclerosis, Other systemic autoimmune diseases), Localized autoimmune disease (Inflammatory bowel disease, Type 1 diabetes, Thyroid, Other localized autoimmune diseases). Based on End User, the market is segmented into Hospitals, Diagnostics centers, Other end-users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Autoimmune Disease Diagnostics Market Analysis By Type
The global Autoimmune Disease Diagnostics market can be segmented based on types, including Systemic and Localized. The dominant segment in the global market is currently the systemic segment. Systemic autoimmune diseases refer to conditions where the immune system attacks multiple organs or systems throughout the body. This segment includes diseases such as rheumatoid arthritis, systemic lupus erythematosus (SLE), systemic sclerosis, and Sjögren's syndrome, among others. Systemic autoimmune diseases have a significant impact on the overall market due to their higher prevalence and broader spectrum of clinical manifestations. Systemic autoimmune diseases dominate the market primarily due to their complex nature and the diverse range of diagnostic tests required for their identification and monitoring. These diseases often require a multidisciplinary approach involving rheumatologists, dermatologists, nephrologists, and other specialists, leading to a higher demand for comprehensive diagnostic tools.
The fastest-growing segment in the global Autoimmune Disease Diagnostics market is localized. The growth of the localized autoimmune diseases segment is fueled by increasing awareness and improved diagnostic capabilities in detecting these diseases. Early and accurate diagnosis of localized autoimmune diseases is gaining importance, as it allows for targeted treatments and improved patient outcomes. This growing recognition of localized autoimmune diseases is driving the demand for specific diagnostic tests tailored to each condition. Moreover, advancements in laboratory techniques, such as molecular diagnostics and genetic testing, have facilitated the identification of specific biomarkers associated with localized autoimmune diseases. This has further contributed to the growth of the segment by enabling more accurate and targeted diagnostic approaches.
Autoimmune Disease Diagnostics Market Analysis By End-User
The global Autoimmune Disease Diagnostics market can also be segmented based on the type of end-user, including hospitals and clinical laboratories. The dominant segment in the global market is hospitals. The segment is equipped with advanced medical infrastructure, including specialized diagnostic departments and access to a wide range of diagnostic tests. Hospitals serve as primary care centers and referral points for patients presenting with autoimmune disease symptoms. As dominant end-users, hospitals have significant advantages in terms of patient access and comprehensive healthcare services. They offer a wide array of diagnostic tests and have dedicated departments staffed with skilled healthcare professionals, including specialists in autoimmune diseases. Hospitals also have the capability to handle complex cases and provide specialized care for patients with severe autoimmune diseases.
Clinical laboratories segment is projected to be the fastest-growing in the autoimmune disease diagnostics market. Clinical laboratories are specialized facilities that focus on performing diagnostic tests and providing laboratory services. These laboratories often collaborate with hospitals, healthcare clinics, and research institutions. Clinical laboratories provide a cost-effective and efficient approach to autoimmune disease diagnostics. They offer dedicated expertise in laboratory testing, ensuring accurate and timely results. With advancements in automation and technology, clinical laboratories are able to process a higher volume of samples, leading to quicker turnaround times and improved patient care.
Global Autoimmune Disease Diagnostics Market By Type
To get detailed analysis on other segments, Request For Free Sample Report
Autoimmune Disease Diagnostics Market Regional Insights
The dominating region in the global Autoimmune Disease Diagnostics market is North America, which holds a significant market share. This dominance can be attributed to several factors, including well-established healthcare infrastructure, high healthcare expenditure, and a significant prevalence of autoimmune diseases in the region. The presence of key market players, technological advancements, and a strong focus on research and development contribute to the region's leadership position. Additionally, favorable reimbursement policies and increased awareness among healthcare providers and patients about autoimmune diseases drive the demand for diagnostic tests in North America.
The Asia Pacific region is experiencing rapid growth in the Global Autoimmune Disease Diagnostics Market. Factors such as increasing healthcare spending, improving healthcare infrastructure, and rising awareness about autoimmune diseases contribute to the market's growth in this region. Moreover, the high population density and changing lifestyles in countries like China and India have led to a rise in autoimmune disease incidence. The growing demand for accurate and timely diagnosis, coupled with advancements in healthcare technology and increased access to healthcare services, drives the market's expansion in the Asia Pacific region. Additionally, initiatives taken by governments to improve healthcare facilities and increase disease awareness further support the market's growth in this region.
Global Autoimmune Disease Diagnostics Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Autoimmune Disease Diagnostics Market Dynamics
Autoimmune Disease Diagnostics Market Drivers
Growing Awareness and Early Diagnosis
- Increased awareness among patients and healthcare professionals about autoimmune diseases has resulted in early recognition of symptoms and timely diagnosis. Early detection enables prompt initiation of treatment and management strategies, improving patient outcomes. This awareness has led to a higher demand for diagnostic tests that aid in early diagnosis and monitoring of autoimmune diseases.
Favorable Reimbursement Policies
- Favorable reimbursement policies and the availability of medical insurance coverage for autoimmune disease diagnostics have contributed to market growth. Accessible and affordable diagnostic tests enable a larger patient population to undergo screening, leading to increased diagnosis rates and better disease management.
Autoimmune Disease Diagnostics Market Restraints
High Cost of Diagnostic Tests
- Autoimmune disease diagnostic tests can be expensive, especially advanced and specialized tests. The high cost of these tests can limit access for patients, particularly in regions with limited healthcare resources or inadequate insurance coverage. The affordability of diagnostic tests remains a significant challenge, hindering widespread adoption and potentially delaying diagnosis and treatment.
Request Free Customization of this report to help us to meet your business objectives.
Autoimmune Disease Diagnostics Market Competitive Landscape
The competitive landscape of the Global Autoimmune Disease Diagnostics Market is characterized by the presence of several key players and a mix of established companies and emerging players. The market is highly competitive, with companies striving to develop advanced diagnostic tools and technologies to gain a competitive edge. In addition to established players, there are also smaller companies and start-ups that are actively engaged in research and development activities to introduce innovative diagnostic technologies. These emerging players often focus on niche areas and aim to disrupt the market with novel approaches and solutions. Collaborations, partnerships, and strategic acquisitions are common in the competitive landscape as companies seek to enhance their product portfolios and expand their market reach. These collaborations enable sharing of expertise, resources, and technologies, leading to the development of more advanced and comprehensive diagnostic solutions. Overall, the competitive landscape of the autoimmune disease diagnostics market is dynamic and characterized by continuous research and development efforts, strategic collaborations, and a focus on technological advancements. The competition among players drives innovation, resulting in the introduction of more accurate, efficient, and patient-centric diagnostic solutions.
Autoimmune Disease Diagnostics Market Top Player’s Company Profiles
- Abbott Laboratories
- Thermo Fisher Scientific Inc.
- Siemens AG
- F. Hoffmann-La Roche Ltd
- Bio-Rad Laboratories, Inc.
- Quest Diagnostics Incorporated
- Hologic, Inc.
- Danaher Corporation
- Inova Diagnostics, Inc.
- PerkinElmer Germany Diagnostics GmbH
- Grifols, S.A.
- Bio-Techne Corporation
- Menarini Group
- Myriad Genetics, Inc.
- Medac GmbH
- ImmunArray
- Exagen Inc.
- ORGENTEC Diagnostika GmbH
- Seramun Diagnostica GmbH
- SQI Diagnostics Inc.
Autoimmune Disease Diagnostics Market Recent Developments
- In August 2022, in order to identify an antigen associated with the autoimmune blistering condition known as mucous membrane pemphigoid (MMP), which frequently results in painful lesions in the oral cavity, KSL Beutner Laboratories (Beutner) developed a blood test.
- In May 2022, in the US, autoimmune testing can be done using Thermofisher's brand-new Phadia 2500+ range of devices. It provides dependable and unmatched high throughput for autoimmune and allergy tests.
Autoimmune Disease Diagnostics Key Market Trends
- Technological Advancements: Advancements in medical technology and diagnostic techniques have greatly improved the accuracy and efficiency of autoimmune disease diagnostics. Innovative laboratory tests, imaging techniques, and specialized assays are enhancing the identification and monitoring of specific autoimmune disorders.
- Growing Awareness: Increasing awareness among patients and healthcare providers about autoimmune diseases and the importance of early detection and diagnosis is fueling market growth. Early recognition of symptoms and timely diagnostic procedures can lead to better patient outcomes and improved disease management.
Autoimmune Disease Diagnostics Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our global Autoimmune Disease Diagnostics market analysis, increasing prevalence of autoimmune diseases worldwide is a major driver of market growth. Factors such as genetic predisposition, environmental triggers, and lifestyle changes contribute to the rising incidence of these diseases. Consequently, the demand for diagnostic tests has surged. Advancements in medical technology and diagnostic techniques have improved the accuracy and efficiency of autoimmune disease diagnostics. Various laboratory tests, imaging techniques, and specialized assays aid in identifying specific autoimmune disorders. These innovations enable healthcare professionals to make informed decisions about patient treatment plans. Growing awareness among patients and healthcare providers has also fueled demand for early detection and diagnosis. Prompt recognition of symptoms and initiation of appropriate diagnostic procedures can greatly improve patient outcomes and prevent complications. The competitive landscape of the market is characterized by numerous companies and research institutions working on developing new diagnostic tools and technologies. Traditional diagnostic laboratories, pharmaceutical companies, biotechnology firms, and academic institutions contribute to the market's growth through continuous research and development efforts. In conclusion, the global market is driven by the increasing prevalence of autoimmune diseases, advancements in diagnostic technology, and growing awareness. The market holds significant potential for further innovation in diagnostic tools that can aid in early detection and effective management of autoimmune diseases.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 4.38 billion |
| Market size value in 2031 | USD 6.32 billion |
| Growth Rate | 4.15% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Autoimmune Disease Diagnostics Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Autoimmune Disease Diagnostics Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Autoimmune Disease Diagnostics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Autoimmune Disease Diagnostics Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Autoimmune Disease Diagnostics Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Autoimmune Disease Diagnostics Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
